| ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Copyright © 2010. National Academy of Sciences. All rights reserved. Terms of Use and Privacy Statement |
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page R1
Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
CANCER-RELATED GENETIC TESTING AND COUNSELING
Workshop Proceedings
National Cancer Policy Forum
INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES
THE NATIONAL ACADEMIES PRESS
Washington, D.C.
www.nap.edu
OCR for page R2
Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
THE NATIONAL ACADEMIES PRESS
500 Fifth Street, N.W. Washington, DC 20001
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.
This study was supported by Contracts No. HHSN261200611002C, 200-2005-13434, TO #1, HHSM-500-2005-00179P, HHSP23320042509XI, TO #4, 223-01-2460, TO #27, HHSH25056133, TO #6 between the National Academy of Sciences and, respectively, the National Cancer Institute, the Centers for Disease Control and Prevention, the Centers for Medicare and Medicaid Services, the Agency for Healthcare Research and Quality, the Food and Drug Administration, and the Health Resources and Services Administration. Support was also received from the American Cancer Society, the American Society of Clinical Oncology, and C-Change. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project.
International Standard Book Number-13: 978-0-309-10977-0
International Standard Book Number-10: 0-309-10977-3
Additional copies of this report are available from the
National Academies Press,
500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet, http://www.nap.edu.
For more information about the Institute of Medicine, visit the IOM home page at: www.iom.edu
Copyright 2007 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America.
The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from ancient Greece, now held by the Staatliche Museen in Berlin.
Suggested citation: Institute of Medicine (IOM). 2007. Cancer-related genetic testing and counseling: Workshop proceedings. Washington, DC: The National Academies Press.
OCR for page R3
Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
“Knowing is not enough; we must apply.
Willing is not enough; we must do.”
—Goethe
INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES
Advising the Nation. Improving Health.
OCR for page R4
Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
THE NATIONAL ACADEMIES
Advisers to the Nation on Science, Engineering, and Medicine
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences.
The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Charles M. Vest is president of the National Academy of Engineering.
The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine.
The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. Charles M. Vest are chair and vice chair, respectively, of the National Research Council.
www.national-academies.org
OCR for page R5
Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
NATIONAL CANCER POLICY FORUM
HAROLD L. MOSES (Chair), Professor of Cancer Biology,
Medicine, and Pathology,
Director Emeritus,
Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University Medical Center
PETER BACH, Associate Member,
Memorial Sloan-Kettering Cancer Center
EDWARD BENZ, President,
Dana-Farber Cancer Institute
THOMAS BURISH, Past Chair,
ACS Board and Provost, Notre Dame University
BETTY FERRELL, Research Scientist,
City of Hope National Medical Center
JOSEPH FRAUMENI, Director,
Division of Cancer Epidemiology and Genetics, National Cancer Institute
STEPHEN FRIEND, Executive Vice President,
Oncology, Merck
PATRICIA GANZ, ASCO Board Member and Professor of Medicine,
University of California at Los Angeles
ROY HERBST, Chief,
Section of Thoracic Medical Oncology, M.D. Anderson Cancer Center
THOMAS KEAN, Executive Director,
C-Change
WILLIAM LAWRENCE, Director,
Center for Outcomes and Evidence, Agency for Healthcare Research and Quality
LYNN MATRISIAN, Chair,
Division of Cancer Biology, Vanderbilt University
JOHN NIEDERHUBER, Director,
National Cancer Institute
DAVID PARKINSON, Senior Vice President,
Oncology Research and Development, Biogen IDEC
EDITH PEREZ, Director,
Cancer Clinical Study Unit, Mayo Clinic
SCOTT RAMSEY, Member,
Fred Hutchinson Cancer Research Center
EDDIE REED, Director,
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention
MARGARET SPITZ, Chair of Epidemiology,
M.D. Anderson Cancer Center
ELLEN STOVALL, President and CEO,
National Coalition for Cancer Survivorship
BARRY STRAUBE, Director,
Office of Clinical Standards and Quality and Chief Medical Officer, CMS
JANET WOODCOCK, Deputy Commissioner and Chief Medical Officer,
Food and Drug Administration
OCR for page R6
Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
Staff
SHARYL NASS, Senior Program Officer
ROGER HERDMAN, Director,
National Cancer Policy Forum
LAURA LEVIT, Research Associate
MARY ANN PRYOR, Senior Program Assistant
This volume has been reviewed in draft form in accordance with procedures approved by the NRC’s Report Review Committee. We wish to thank Betty Ferrell, Ph.D., FAAN, for her review and Clyde Behney for serving as coordinator of the review.
OCR for page R7
Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
Contents
Abbreviations and Acronyms
ix
1
Introduction
1
2
Prepared Presentations and Discussion
3
References
117
Appendix: Workshop Agenda
121
OCR for page R8
Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
This page intentionally left blank.
OCR for page R9
Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
Abbreviations and Acronyms
AAFP American Academy of Family Practitioners
ACMG American College of Medical Genetics
ACS American Cancer Society
AHRQ Agency for Healthcare Research and Quality
AMA American Medical Association
ASCO American Society of Clinical Oncology
ASHG American Society of Human Genetics
ASR analyte-specific reagent
CDC Centers for Disease Control and Prevention
CLIA Clinical Laboratory Improvement Amendments of 1988, or CLIA
CME continuing medical education
CMS Centers for Medicare and Medicaid Services
CPT current procedural terminology
DHHS Department of Health and Human Services
DOE Department of Energy
DTC direct-to-consumer
ELSI ethical, legal, and social implications
FAP familial adenomatous polyposis
OCR for page R10
Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
FDA Food and Drug Administration
FTC Federal Trade Commission
FTE full-time equivalent
GAO Government Accountability Office
GI gastrointestinal
GINA Genetic Information Nondiscrimination Act
GNRH gonadotrophin-releasing hormone
GRE Graduate Record Examination
HIPAA Health Insurance Portability and Accountability Act
HMO health maintenance organization
HNPCC hereditary nonpolyposis colorectal cancer
HRSA Health Resources and Services Administration
IOM Institute of Medicine
IRB institutional review board
IVDMIA in vitro diagnostic multivariate index assay
MRI magnetic resonance imaging
NCCN National Comprehensive Cancer Network
NCI National Cancer Institute
NIH National Institutes of Health
NPI national provider identification
NSABP B-04 National Surgical Adjuvant Breast and Bowel Project
NSGC National Society of Genetic Counselors
OCN oncology-certified nurse
PSA prostate specific antigen
RBRVS resource-based relative value system
RVU relative value unit
UPIN universal provider identification number
USC University of Southern California
USPSTF U.S. Preventive Services Task Force